Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Tirzepatide for treatment of postbariatric hypoglycemia after Roux-en-Y gastric bypass: a report of 3 cases.
Journal: JCEM case reports
Published: February 20, 2026
Tirzepatide as an Add-on for Participants with Inadequate Glycemic Control Using Basal Insulin: Pooled Subgroup Analysis of SURPASS-5 and -6.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: November 19, 2025
Insights into the Mechanism of Action of Tirzepatide: A Narrative Review.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: June 24, 2025
Early Fasting Serum Glucose or Weight Reduction With Tirzepatide and Metabolic Outcomes in People With Type 2 Diabetes: A Post Hoc Analysis of the SURPASS Trials.
Journal: Diabetes care
Published: December 16, 2024
Model-based simulation of glycaemic effect and body weight loss when switching from semaglutide or dulaglutide to once weekly tirzepatide.
Journal: Current medical research and opinion
Published: February 26, 2024
Predictors of ≥15% Weight Reduction and Associated Changes in Cardiometabolic Risk Factors With Tirzepatide in Adults With Type 2 Diabetes in SURPASS 1-4.
Journal: Diabetes care
Published: June 20, 2023
Efficacy and Safety of Tirzepatide in Adults With Type 2 Diabetes: A Perspective for Primary Care Providers.
Journal: Clinical diabetes : a publication of the American Diabetes Association
Published: April 24, 2023
Major β cell-specific functions of NKX2.2 are mediated via the NK2-specific domain.
Journal: Genes & development
Published: February 25, 2023
Achievement of glycaemic targets with weight loss and without hypoglycaemia in type 2 diabetes with the once-weekly glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist tirzepatide: A post hoc analysis of the SURPASS-1 to -5 studies.
Journal: Diabetes, obesity & metabolism
Published: October 03, 2022
Are we there yet? Increasing use of cardioprotective antihyperglycemic agents in patients with T2D and CVD or CV risk in the United States.
Journal: Current medical research and opinion
Published: June 27, 2022
Efficacy of tirzepatide 5, 10 and 15 mg versus semaglutide 2 mg in patients with type 2 diabetes: An adjusted indirect treatment comparison.
Journal: Diabetes, obesity & metabolism
Published: March 31, 2022
Examining the evidence for weight management in individuals with type 2 diabetes.
Journal: Diabetes, obesity & metabolism
Published: January 26, 2022
Last Updated: 09/26/2026